|
|
|
40
|
1201P
|
AZARGA 1% | 0.5% EYE DR (NVS/COL) BRINZOLAMIDE |
|
BRINZOLAMIDE|TIMOLOL
|
AZARGA
|
5ML
|
C
|
19.79
|
19.79
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
1201P
|
AZARGA 1%|0.5% EYE DR (NVS) BRINZOLAMIDE|TIMOLOL (BQ)
|
BRINZOLAMIDE|TIMOLOL
|
AZARGA
|
5ML
|
BQ
|
19.79
|
19.7894
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
1201P
|
AZARGA 1%|0.5% EYE DR (NVS) BRINZOLAMIDE|TIMOLOL
|
BRINZOLAMIDE|TIMOLOL
|
AZARGA
|
5ML
|
BQ
|
19.79
|
19.79
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
524092
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
ANTIGLAUCOMA AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
14624
|
TEGRETOL 200MG TAB (NVS/COL) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
100'S
|
A
|
38.25
|
0.38
|
TABLET
|
240
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
14624
|
TEGRETOL 200MG TAB (NVS) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
100'S
|
A
|
38.25
|
0.3825
|
TAB
|
240
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
14624
|
TEGRETOL 200MG TAB (NVS) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
100'S
|
A
|
38.25
|
0.38
|
TAB
|
240
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
14632
|
TEGRETOL 20MG/ML SYR (NVS/COL) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
100ML
|
A
|
7.80
|
0.08
|
SYRUP
|
900
|
ML
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
14632
|
TEGRETOL 20MG/ML SYR (NVS) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
100ML
|
A
|
10.14
|
0.1014
|
ML
|
900
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
14632
|
TEGRETOL 20MG/ML SYR (NVS) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
100ML
|
A
|
12.07
|
0.12
|
ML
|
900
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
14641
|
TEGRETOL CR 400MG TAB (NVS/COL) CARBAMAZEPINE
|
CARBAMAZEPINE CR
|
TEGRETOL CR
|
30'S
|
A
|
21.94
|
0.73
|
TABLET
|
120
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
14641
|
TEGRETOL CR 400MG TAB (NVS) CARBAMAZEPINE CR
|
CARBAMAZEPINE CR
|
TEGRETOL CR
|
30'S
|
A
|
21.94
|
0.7313
|
TABCR
|
120
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
14641
|
TEGRETOL 400MG CR TAB (NVS) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
30'S
|
A
|
21.94
|
0.73
|
TAB
|
120
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
14651
|
TEGRETOL CR 200MG TAB (NVS/COL) CARBAMAZEPINE
|
CARBAMAZEPINE CR
|
TEGRETOL CR
|
50'S
|
A
|
17.23
|
0.34
|
TABLET
|
240
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
14651
|
TEGRETOL 200MG CR TAB (NVS) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
50'S
|
A
|
17.23
|
0.3446
|
TABCR
|
240
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
14651
|
TEGRETOL 200MG CR TAB (NVS) CARBAMAZEPINE
|
CARBAMAZEPINE
|
TEGRETOL
|
50'S
|
A
|
17.23
|
0.34
|
TAB
|
240
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
17213
|
RITALIN 10MG TAB (NVS/COL) METHYLPHENIDATE
|
METHYLPHENIDATE
|
RITALIN
|
30'S
|
C
|
11.82
|
0.39
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
17213
|
RITALIN 10MG TAB (NVS) METHYLPHENIDATE (C)
|
METHYLPHENIDATE
|
RITALIN
|
30'S
|
C
|
21.12
|
0.704
|
TAB
|
84
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
2820
|
RESPIRATORY-CEREBRAL STIMULANTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
RESPIRATORY-CEREBRAL STIMULANTS
|
|
|
|
|
42
|
17213
|
RITALIN 10MG TAB (NVS) METHYLPHENIDATE
|
METHYLPHENIDATE
|
RITALIN
|
30'S
|
C
|
17.59
|
0.59
|
TAB
|
84
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
282032
|
RESPIRATORY-CNS STIMULANTS
|
2026-04-01
|
|
|
ORAL
|
6
|
RESPIRATORY-CNS STIMULANTS
|
|
|
|
|
40
|
41011
|
ZOMETA 4MG INJ (NVS/COL) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
842.68
|
842.68
|
INJECTION
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
41011
|
ZOMETA 4MG INJ (NVS) ZOLENDRONIC ACID (C)
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
706.76
|
706.7642
|
VIAL
|
2
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
BONE RESORPTION INHIBITORS
|
|